| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 5, 2002
From the Outcomes Research Institute and the Department of Anesthesiology (A.G.D., C.-M.L., M.-I.S., E.B.L., R.L., N.M., O.A., Y.M.S., D.I.S.), Louisville, Ky; the Department of Anesthesiology (C.-M.L.), Chang Gung Memorial Hospital, Taipei, Taiwan; the Department of Anesthesia, Tokyo Women's Medical College (N.M.), Tokyo, Japan; the Department of Anaesthesia (A.R.B.), Royal Melbourne Hospital, Parkville, Australia; and the Ludwig Boltzmann Institute (D.I.S.), University of Vienna, Vienna, Austria. * To whom correspondence should be addressed. E-mail: agdoufas{at}louisville.edu.
Background and Purpose--Hypothermia might prove to be therapeutically beneficial in stroke victims; however, even mild hypothermia provokes vigorous shivering. Meperidine and dexmedetomidine each linearly reduce the shivering threshold (triggering core temperature) with minimal sedation. We tested the hypothesis that meperidine and dexmedetomidine synergistically reduce the shivering threshold without producing substantial sedation or respiratory depression. Methods--We studied 10 healthy male volunteers (18 to 40 years) on 4 days: (1) control (no drug); (2) meperidine (target plasma level 0.3 µg/mL); (3) dexmedetomidine (target plasma level 0.4 ng/mL); and (4) meperidine plus dexmedetomidine (target plasma levels of 0.3 µg/mL and 0.4 ng/mL, respectively). Lactated Ringer's solution ( Results--The shivering thresholds on the study days were as follows: control, 36.7±0.3°C; dexmedetomidine, 36.0±0.5°C (P<0.001 from control); meperidine, 35.5±0.6°C (P<0.001); and meperidine plus dexmedetomidine, 34.7±0.6°C (P<0.001). Although meperidine and dexmedetomidine each reduced the shivering threshold, their interaction was not synergistic but additive (P=0.19). There was trivial sedation with either drug alone or in combination. Respiratory rate and end-tidal PCO2 were well preserved on all days. Conclusions--Dexmedetomidine and meperidine additively reduce the shivering threshold; in the small doses tested, the combination produced only mild sedation and no respiratory toxicity.
Accepted on December 10, 2002
Dexmedetomidine and Meperidine Additively Reduce the Shivering Threshold in Humans
Anthony G. Doufas MD, PhD*;
4°C) was infused through a central venous catheter to decrease tympanic membrane temperature by
2.5°C/h; mean skin temperature was maintained at 31°C. An increase in oxygen consumption >25% of baseline identified the shivering threshold. Sedation was evaluated by using the Observer's Assessment of Sedation/Alertness scale. Two-way repeated-measures ANOVA was used to identify interactions between drugs. Data are presented as mean±SD; P<0.05 was statistically significant.
This article has been cited by other articles:
![]() |
T. M. Hemmen and P. D. Lyden Induced Hypothermia for Acute Stroke Stroke, February 1, 2007; 38(2): 794 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Komatsu, M. Orhan-Sungur, J. In, T. Podranski, T. Bouillon, R. Lauber, S. Rohrbach, and D. Sessler Ondansetron does not reduce the shivering threshold in healthy volunteers Br. J. Anaesth., June 1, 2006; 96(6): 732 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wadhwa, P. Sengupta, J. Durrani, O. Akca, R. Lenhardt, D. I. Sessler, and A. G. Doufas Magnesium sulphate only slightly reduces the shivering threshold in humans Br. J. Anaesth., June 1, 2005; 94(6): 756 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Paris, C. Ohlendorf, M. Marquardt, B. Bein, J. M. Sonner, J. Scholz, and P. H. Tonner The Effect of Meperidine on Thermoregulation in Mice: Involvement of {alpha}2-Adrenoceptors Anesth. Analg., January 1, 2005; 100(1): 102 - 106. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |